Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.

Biomolecules · 2021 · PMC7828218 · PMID 33445810

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

showed a trend of sarilumab to improve the clinical outcome in severe cases of COVID-19, compared to SOC-treated patients, albeit with only 53 participants in the study [ 87 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.